Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: Cognitive Effects of Bioavailable Curcumin [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating whether a bioavailable curcumin formulation improves memory and cognitive function in individuals with cognitive decline; currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (bioavailable formulation) (curcumin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Memory, Cognitive Function Decline | Phase 2 | Status: NOT_YET_RECRUITING